Risk of symptomatic intracerebral hemorrhage after intravenous thrombolysis in patients with acute ischemic stroke and high cerebral microbleed burden ameta-analysis

JAMA Neurology

Volumn 73, Issue 6, 2016, Pages 675-683

  Tsivgoulis, Georgios ^a,b,c   Zand, Ramin ^a   Katsanos, Aristeidis H ^b,d   Turc, Guillaume ^e   Nolte, Christian H ^f   Jung, Simon ^g   Cordonnier, Charlotte ^h   Fiebach, Jochen B ^f   Scheitz, Jan F ^f   Klinger Gratz, Pascal P ^g   Oppenheim, Catherine ^e   Goyal, Nitin ^a   Safouris, Apostolos ^b,i   Mattle, Heinrich P ^g   Alexandrov, Anne W ^a,j   Schellinger, Peter D ^k   Alexandrov, Andrei V ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^d UNIVERSITY OF IOANNINA   (Greece)

^e CENTRE HOSPITALIER SAINTE ANNE   (France)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^g UNIVERSITY OF BERN   (Switzerland)

^h UNIV LILLE   (France)

ⁱ METROPOLITAN HOSPITAL   (Greece)

^j AUSTRALIAN CATHOLIC UNIVERSITY   (Australia)

^k KLINIKUM MINDEN   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; TISSUE PLASMINOGEN ACTIVATOR; FIBRINOLYTIC AGENT;

ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; HUMAN; META ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK; RISK ASSESSMENT; RISK FACTOR; RISK RATIO; SYMPTOMATIC INTRACEREBRAL HEMORRHAGE; SYSTEMATIC REVIEW; BIBLIOGRAPHIC DATABASE; CEREBRAL HEMORRHAGE; CHEMICALLY INDUCED; COMPLICATION; DIAGNOSTIC IMAGING; INTRAVENOUS DRUG ADMINISTRATION; STATISTICS AND NUMERICAL DATA; STROKE;

ADMINISTRATION, INTRAVENOUS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; DATABASES, BIBLIOGRAPHIC; FIBRINOLYTIC AGENTS; HUMANS; MAGNETIC RESONANCE IMAGING; RISK FACTORS; STROKE;

EID: 84974625093     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2016.0292     Document Type: Article

References (46)

1. Linn J. Imaging of cerebral microbleeds. Clin Neuroradiol. 2015;25(suppl 2):167-175.
2. Senior K. Microbleeds may predict cerebral bleeding after stroke. Lancet. 2002;359(9308):769.
3. Shoamanesh A, Yan S, Charidimou A. New Cerebral microbleeds and mechanism of post-thrombolysis remote intracerebral hemorrhage: "red meets white" revisited. Front Neurol. 2015;6:203.
4. Kim BJ, Lee SH. Cerebral microbleeds: their associated factors, radiologic findings, and clinical implications. J Stroke. 2013;15(3):153-163.
5. Shoamanesh A, Kwok CS, Lim PA, Benavente OR. Postthrombolysis intracranial hemorrhage risk of cerebral microbleeds in acute stroke patients: a systematic review and meta-analysis. Int J Stroke. 2013;8(5):348-356.
6. Charidimou A, Shoamanesh A, Wilson D, et al. Cerebral microbleeds and postthrombolysis intracerebral hemorrhage risk Updated meta-analysis. Neurology. 2015;85(11):927-934. doi:10.1212/WNL.0000000000001923.
7. Charidimou A,Werring DJ. Cerebral microbleeds as a predictor of macrobleeds: what is the evidence? Int J Stroke. 2014;9(4):457-459.
8. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62(10):e1-e34.
9. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting: Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283 (15):2008-2012.
10. Goyal N, Tsivgoulis G, Male S, Bhaskaran D, Alexandrov AV, Zand R. Feasibility of rapid short sequence magnetic resonance imaging for screening stroke mimics within the iv-tpa treatment window: a pilot study. Poster presented at: International Stroke Conference 2015; February 11-12, 2015; Nashville, TN.
11. Wardlaw JM, Smith EE, Biessels GJ, et al; STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1). Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12(8):822-838.
12. Riley RD, Lambert PC, Abo-Zaid G. Meta-analysis of individual participant data: rationale, conduct, and reporting. BMJ. 2010;340:c221.
13. Deeks JJ, Higgins JP, Altman DG. Chapter 9: Analysing data and undertaking meta-analyses. Cochrane Handbook for Systematic Reviews of Interventions website. http://handbook.cochrane.org/chapter-9/9-analysing-data-and-undertaking-meta-analyses.htm. Published March 2011. Accessed February 4, 2014.
14. Sterne JA, Sutton AJ, Ioannidis JP, et al. Recommendations for examining and interpreting funnel plot asymmetry inmeta-analyses of randomised controlled trials. BMJ. 2011;343:d4002.
15. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629-634.
16. Kidwell CS, Saver JL, Villablanca JP, et al. Magnetic resonance imaging detection of microbleeds before thrombolysis: an emerging application. Stroke. 2002;33(1):95-98.
17. Kim HS, Lee DH, Ryu CW, et al. Multiple cerebral microbleeds in hyperacute ischemic stroke: impact on prevalence and severity of early hemorrhagic transformation after thrombolytic treatment. AJR Am J Roentgenol. 2006;186(5):1443-1449.
18. Moriya Y, TakahashiW, Kijima C, et al. Predictors for hemorrhagic transformation with intravenous tissue plasminogen activator in acute ischemic stroke. Tokai J Exp Clin Med. 2013;38(1): 24-27.
19. Yan S, Chen Y, Zhang X, Liebeskind DS, Lou M. New microbleeds after thrombolysis: contiguous thin-slice 3T MRI. Medicine (Baltimore). 2014;93 (20):e99.
20. Dannenberg S, Scheitz JF, Rozanski M, et al. Number of cerebral microbleeds and risk of intracerebral hemorrhage after intravenous thrombolysis. Stroke. 2014;45(10):2900-2905.
21. Derex L, Nighoghossian N, Hermier M, et al. Thrombolysis for ischemic stroke in patients with oldmicrobleeds on pretreatment MRI. Cerebrovasc Dis. 2004;17(2-3):238-241.
22. Fiehler J, Albers GW, Boulanger JM, et al;MR STROKE Group. Bleeding risk analysis in stroke imaging before thrombolysis (BRASIL): pooled analysis of T2∗-weighted magnetic resonance imaging data from 570 patients. Stroke. 2007;38 (10):2738-2744.
23. Gratz PP, El-Koussy M, Hsieh K, et al. Preexisting cerebral microbleeds on susceptibility-weighted magnetic resonance imaging and post-thrombolysis bleeding risk in 392 patients. Stroke. 2014;45(6):1684-1688.
24. KakudaW, Thijs VN, Lansberg MG, et al; DEFUSE Investigators. Clinical importance of microbleeds in patients receiving IV thrombolysis. Neurology. 2005;65(8):1175-1178.
25. Kimura K, Aoki J, Shibazaki K, Saji N, Uemura J, Sakamoto Y. New appearance of extraischemic microbleeds on T2∗-weighted magnetic resonance imaging 24 hours after tissue-type plasminogen activator administration. Stroke. 2013;44(10): 2776-2781.
26. Turc G, Sallem A, Moulin S, et al.Microbleed status and 3-month outcome after intravenous thrombolysis in 717 patients with acute ischemic stroke. Stroke. 2015;46(9):2458-2463.
27. Yan S, Jin X, Zhang X, Zhang S, Liebeskind DS, LouM. Extensive cerebral microbleeds predict parenchymal haemorrhage and poor outcome after intravenous thrombolysis. J Neurol Neurosurg Psychiatry. 2015;86(11):1267-1272.
28. HackeW, Kaste M, Fieschi C, et al; Second European-Australasian Acute Stroke Study Investigators. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet. 1998;352(9136):1245-1251.
29. Akoudad S, Portegies ML, Koudstaal PJ, et al. Cerebral microbleeds are associated with an increased risk of stroke: The Rotterdam Study. Circulation. 2015;132(6):509-516.
30. Fisher M. Cerebral microbleeds: where are we now? Neurology. 2014;83(15):1304-1305.
31. Jeerakathil T,Wolf PA, Beiser A, et al. Cerebral microbleeds: prevalence and associations with cardiovascular risk factors in the Framingham Study. Stroke. 2004;35(8):1831-1835.
32. Poels MM, VernooijMW, IkramMA, et al. Prevalence and risk factors of cerebral microbleeds: an update of the Rotterdam scan study. Stroke. 2010;41(10)(suppl):S103-S106.
33. Yang Q, Yang Y, Li C, et al. Quantitative assessment and correlation analysis of cerebral microbleed distribution and leukoaraiosis in stroke outpatients. Neurol Res. 2015;37(5):403-409.
34. Fisher M, French S, Ji P, Kim RC. Cerebral microbleeds in the elderly: a pathological analysis. Stroke. 2010;41(12):2782-2785.
35. Gregg NM, KimAE, GurolME, et al. Incidental cerebral microbleeds and cerebral blood flowin elderly individuals. JAMANeurol. 2015;72(9):1021-1028.
36. Pantoni L, Fierini F, Poggesi A. Thrombolysis in acute stroke patients with cerebral small vessel disease. Cerebrovasc Dis. 2014;37(1):5-13.
37. Wong KS, Chan YL, Liu JY, Gao S, LamWW. Asymptomatic microbleeds as a risk factor for aspirin-associated intracerebral hemorrhages. Neurology. 2003;60(3):511-513.
38. Roob G, Lechner A, Schmidt R, Flooh E, Hartung HP, Fazekas F. Frequency and location of microbleeds in patients with primary intracerebral hemorrhage. Stroke. 2000;31(11):2665-2669.
39. Tsivgoulis G, Kotsis V, Giannopoulos S. Intravenous thrombolysis for acute ischaemic stroke: effective blood pressure control matters. Int J Stroke. 2011;6(2):125-127.
40. Charidimou A, Fox Z,Werring DJ. Do cerebral microbleeds increase the risk of intracerebral hemorrhage after thrombolysis for acute ischemic stroke? Int J Stroke. 2013;8(3):E1-E2.
41. Lin WM, Yang TY,Weng HH, et al. Brain microbleeds: distribution and influence on hematoma and perihematomal edema in patients with primary intracerebral hemorrhage. Neuroradiol J. 2013;26(2):184-190.
42. Gerischer LM, Fiebach JB, Scheitz JF, Audebert HJ, Endres M, Nolte CH. Magnetic resonance imaging-based versus computed tomographybased thrombolysis in acute ischemic stroke: comparison of safety and efficacy within a cohort study. Cerebrovasc Dis. 2013;35(3):250-256.
43. Cheng AL, Batool S, McCreary CR, et al. Susceptibility-weighted imaging is more reliable than T2∗-weighted gradient-recalled echo MRI for detectingmicrobleeds. Stroke. 2013;44(10):2782-2786.
44. Goos JD, van der Flier WM, Knol DL, et al. Clinical relevance of improve-dmicrobleed detection by susceptibility-weighted magnetic resonance imaging. Stroke. 2011;42(7):1894-1900.
45. Lewin JS, Duerk JL, Jain VR, Petersilge CA, Chao CP, Haaga JR. Needle localization in MR-guided biopsy and aspiration: effects of field strength, sequence design, and magnetic field orientation. AJR AmJ Roentgenol. 1996;166(6): 1337-1345.
46. Soher BJ, Dale BM, Merkle EM. A review ofMR physics: 3T versus 1.5T. Magn Reson Imaging Clin NAm. 2007;15(3):277-290.